rs139753431

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_033305.3(VPS13A):ā€‹c.7053T>Cā€‹(p.Ala2351Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,609,510 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0058 ( 12 hom., cov: 32)
Exomes š‘“: 0.00062 ( 14 hom. )

Consequence

VPS13A
NM_033305.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.639
Variant links:
Genes affected
VPS13A (HGNC:1908): (vacuolar protein sorting 13 homolog A) The protein encoded by this gene may control steps in the cycling of proteins through the trans-Golgi network to endosomes, lysosomes and the plasma membrane. Mutations in this gene cause the autosomal recessive disorder, chorea-acanthocytosis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 9-77344179-T-C is Benign according to our data. Variant chr9-77344179-T-C is described in ClinVar as [Benign]. Clinvar id is 448870.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-77344179-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.639 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00575 (876/152248) while in subpopulation AFR AF= 0.0203 (845/41558). AF 95% confidence interval is 0.0192. There are 12 homozygotes in gnomad4. There are 408 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
VPS13ANM_033305.3 linkuse as main transcriptc.7053T>C p.Ala2351Ala synonymous_variant 51/72 ENST00000360280.8 NP_150648.2 Q96RL7-1
VPS13ANM_001018037.2 linkuse as main transcriptc.6936T>C p.Ala2312Ala synonymous_variant 50/71 NP_001018047.1 Q96RL7-3
VPS13ANM_015186.4 linkuse as main transcriptc.7053T>C p.Ala2351Ala synonymous_variant 51/69 NP_056001.1 Q96RL7-2
VPS13ANM_001018038.3 linkuse as main transcriptc.7053T>C p.Ala2351Ala synonymous_variant 51/69 NP_001018048.1 Q96RL7-4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
VPS13AENST00000360280.8 linkuse as main transcriptc.7053T>C p.Ala2351Ala synonymous_variant 51/721 NM_033305.3 ENSP00000353422.3 Q96RL7-1
VPS13AENST00000376636.7 linkuse as main transcriptc.6936T>C p.Ala2312Ala synonymous_variant 50/711 ENSP00000365823.3 Q96RL7-3
VPS13AENST00000643348.1 linkuse as main transcriptc.7053T>C p.Ala2351Ala synonymous_variant 51/69 ENSP00000493592.1 Q96RL7-2
VPS13AENST00000645632.1 linkuse as main transcriptc.7053T>C p.Ala2351Ala synonymous_variant 51/69 ENSP00000496361.1 Q96RL7-4

Frequencies

GnomAD3 genomes
AF:
0.00574
AC:
873
AN:
152130
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0203
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00138
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00383
GnomAD3 exomes
AF:
0.00156
AC:
393
AN:
251326
Hom.:
6
AF XY:
0.00110
AC XY:
149
AN XY:
135870
show subpopulations
Gnomad AFR exome
AF:
0.0219
Gnomad AMR exome
AF:
0.000781
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000620
AC:
904
AN:
1457262
Hom.:
14
Cov.:
30
AF XY:
0.000567
AC XY:
411
AN XY:
725260
show subpopulations
Gnomad4 AFR exome
AF:
0.0228
Gnomad4 AMR exome
AF:
0.000917
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000128
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000451
Gnomad4 OTH exome
AF:
0.00139
GnomAD4 genome
AF:
0.00575
AC:
876
AN:
152248
Hom.:
12
Cov.:
32
AF XY:
0.00548
AC XY:
408
AN XY:
74450
show subpopulations
Gnomad4 AFR
AF:
0.0203
Gnomad4 AMR
AF:
0.00137
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00379
Alfa
AF:
0.00188
Hom.:
2
Bravo
AF:
0.00692
Asia WGS
AF:
0.000578
AC:
2
AN:
3472
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 07, 2019- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 18, 2018- -
Chorea-acanthocytosis Benign:2
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
6.9
DANN
Benign
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139753431; hg19: chr9-79959095; API